Learn More
OBJECTIVES The purposes of this study were to: 1) characterize physical performance in individuals with human immunodeficiency virus; and 2) examine group differences by pain and fatigue on a multivariate profile of disease, physical, and psychologic symptoms. METHODS One hundred outpatients, 78 men and 22 women (mean age 40.70 +/- 7.49 years)(More)
Thirty HIV-1-positive samples from Bolivia were genetically characterized on the basis of HMA and DNA sequencing, revealing the presence of B and F subtypes, in accordance with the molecular epidemiology pattern already described for other South American countries such as Brazil and Argentina. The interpatient divergence of subtype B Bolivian specimens was(More)
BACKGROUND Pain, sleep, and functional disturbances are a common occurrence in people living with HIV/AIDS-related distal sensory peripheral neuropathy (PLWHA-DSPN) yet lack group classification and quantification. METHODS A total of 46 PLWHA-DSPN were recruited, as part of a 2-group intervention study, to complete the Neuropathic Pain Scale and the(More)
INTRODUCTION The pain associated with peripheral neuropathy (PN) observed in patients living with HIV/AIDS represents a difficult complication to manage. PARTICIPANTS A total of 22 participants with a diagnosis of PN were recruited to assess the effects of using night splints on pain and sleep quality. METHODS For 3 weeks, the participants were(More)
STUDY DESIGN Case report. BACKGROUND Twenty-five percent of people living with HIV/AIDS (PLWHA) are also coinfected with hepatitis C virus (HCV). There are limited reports to assist in the symptom management of PLWHA and HCV coinfection. CASE DESCRIPTION Our case was a 67-year-old man living with HIV/HCV coinfection and other medical complications. Our(More)
BACKGROUND/AIMS Distal symmetrical peripheral neuropathy (DSPN) and sleep disturbances are among the most common complications reported in people living with the human immunodeficiency virus infection and acquired immunodeficiency syndrome (PLWHA). DSPN-pain is predominantly managed by using systemic agents with little evidence supporting their analgesic(More)
  • 1